Search results for: 'Preferred Destination for Clinical Trials'

The increasing disposable incomes in developing countries have contributed to a sedentary lifestyle worldwide. The advent of food delivery apps has also increased accessibility to various culinary delights. These factors have contributed mainly to obesity and other lifestyle diseases. People with a body mass index (BMI) of more than or equal to...

Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasing global cancer burden is a key factor driving the...

Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2018 that centered around the state of their laboratories in 2018 and their expectations for 2019. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents year-o...

30 Jun 2022  |  Global  |  Market Research

Global Airline and Tourism Growth Opportunities

Transformative Mega Trends and Industry Convergence through Airline Partnerships Drive Tourism Growth

Infographics

×

Key Issues Addressed

This Frost & Sullivan study investigates the relationship between popular tourist destinations and the airline agreements of their top carriers, identifying each destination’s primary source countries of international tourism. Europe topped the list of 10 destinations as the most popular tourist region in 2019, with 5 European countries having a fo...

Patients with long-term chronic conditions and rare diseases are looking for safe, novel, and evidence-based digital treatments in their pursuit to reduce dosages and reverse triggers of adverse events. Payers and providers are looking for legitimate alternatives to expensive medication for their patient population. Life sciences (LS) companies are...

This study identifies relevant market drivers and restraints and analyzes current regulatory, market and technology developments. It discusses origination and termination trends by world region and trends by call destination, origination device and end user type.

This study explores the global immuno-oncology (I-O) markets evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned by Frost & Sullivan to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune syst...

The healthcare industry has been adapting to changes induced by the COVID-19 pandemic. Medtech, for its part, has been pursuing mergers and acquisitions (M&As) to implement reforms and help the industry recover. Companies in the traditional clinical segments in medtech, such as orthopedics, cardiology, ear, nose, and throat (ENT), wound care, urolo...

20 Aug 2024  |  Global  |  Technology Research

Technological Advances in Regenerative Medicine

Disruptive Technology and a Competitive Landscape Drive Growth in Stem Cell Therapy Research

Infographics

×

Regenerative medicine has evolved significantly and today includes several commercialized stem cell therapies. Researchers have made notable technological developments in stem cell therapies to overcome challenges related to large-scale manufacturing and cell quality. Stem cell research is more focused on induced pluripotent stem cells than on mese...